Theoretical model of SH2-dependent STAT1 dimerization as a novel tool to identify specific compounds of functional inhibition
2012/07/N/NZ2/01359
Keywords
Descriptors
- NZ2_7: Bioinformatyka
- NZ1_9: Biotechnologia
- ST4_15: Chemia teoretyczna i obliczeniowa
Panel
NZ2 – Genetics, genomics: molecular genetics, genomics, proteomics, bioinformatics, systems biology, genetic epidemiology
Host institution
Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii
Voivodeship: wielkopolskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 3
Call
PRELUDIUM 4 – announced on 2012-09-15
- Amount awarded
- 150 000 PLN
- Project start date
- 2013-07-17
- Project end date
- 2016-07-16
- Project duration
- 36 months (the same as in the proposal)
- Project status
- Project settled
Equipment purchased [PL]
- Komputer wieloprocesorowy z monitorem 27-calowym. Cost: 6 000 PLN
Information in the final report
Publication in academic press/journals (7)
-
Comparative screening and validation as a novel tool to identify STAT-specific inhibitors
- Authors:
- Szeląg M., Czerwoniec A., Wesoły J., Bluyssen H.A.R.
- Academic press:
- European Journal of Pharmacology (year: 2014, volume: 740, pages: 417-420), Publisher: Elsevier
- Status:
- Published
- DOI:
- 10.1016/j.ejphar.2014.05.047 – link to the publication
-
Identyfication of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validation
- Authors:
- Szeląg M., Czerwoniec A., Wesoły J., Bluyssen H.A.R.
- Academic press:
- PLoS One (year: 2015, volume: 10(2), pages: e0116688), Publisher: Public Library of Science
- Status:
- Published
- DOI:
- 10.1371/journal.pone.0116688 – link to the publication
-
Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease
- Authors:
- Szelag M, Piaszyk-Borychowska A, Plens-Galaska M, Wesoly J, Bluyssen HAR
- Academic press:
- Oncotarget (year: 2016, volume: 7(30), pages: 48788-48812), Publisher: Impact Journals
- Status:
- Published
- DOI:
- 10.18632/oncotarget.9195 – link to the publication
-
CAVS – Novel in silico selection strategy of specific STAT inhibitory compounds
- Authors:
- Czerwoniec A., Szelag M., Juszczak K., Wesoly J., Bluyssen H.A.R.
- Academic press:
- Journal of Computational Science (year: 2015, volume: -, pages: -), Publisher: Elsevier
- Status:
- Published
- DOI:
- 10.1016/j.jocs.2015.03.001 – link to the publication
-
Advances in peptidic and peptidomimetic-based approaches to inhibit STAT signaling in human diseases
- Authors:
- Szelag M., Wesoly J., Bluyssen H.A.R.
- Academic press:
- Current Protein and Peptide Science (year: 2016, volume: 17, pages: 135-146), Publisher: Bentham Science
- Status:
- Published
- DOI:
- 10.2174/1389203716666151102103706 – link to the publication
-
In silico simulations of STAT1 and STAT3 inhibitors predict SH2 domain cross-binding specificity
- Authors:
- Szeląg M., Sikorski K., Czerwoniec A., Szatkowska K., Wesoły J., Bluyssen H.A.R.
- Academic press:
- European Journal of Pharmacology (year: 2013, volume: 720, pages: 38-48), Publisher: Elsevier
- Status:
- Published
- DOI:
- 10.1016/j.ejphar.2013.10.055 – link to the publication
-
A theoretical antioxidant pharmacophore for natural hydroxycinnamic acids
- Authors:
- Szelag M., Urbaniak A., Bluyssen H.A.R.
- Academic press:
- Open Chemistry (year: 2015, volume: 13, pages: 17-31), Publisher: De Gruyter
- Status:
- Published
- DOI:
- 10.1515/chem-2015-0001 – link to the publication